Fair and cost-conscious allocation of omalizumab, a groundbreaking food allergy therapy
Ann Allergy Asthma Immunol. 2024 Jul;133(1):18-19. doi: 10.1016/j.anai.2024.04.020. NO ABSTRACT PMID:38960561 | DOI:10.1016/j.anai.2024.04.020
Ann Allergy Asthma Immunol. 2024 Jul;133(1):18-19. doi: 10.1016/j.anai.2024.04.020. NO ABSTRACT PMID:38960561 | DOI:10.1016/j.anai.2024.04.020
CPT Pharmacometrics Syst Pharmacol. 2024 Jul 3. doi: 10.1002/psp4.13193. Online ahead of print. ABSTRACT Clinical trials seeking to delay or prevent the onset of type …
J Transl Med. 2024 Jul 3;22(1):615. doi: 10.1186/s12967-024-05359-5. ABSTRACT OBJECTIVE: To explore the correlation between asthma risk and genetic variants affecting the expression or function …
Pilot Feasibility Stud. 2024 Jul 3;10(1):97. doi: 10.1186/s40814-024-01522-3. ABSTRACT In the dynamic landscape of global health, the journey from a new development to its implementation …
Breast Cancer Res. 2024 Jul 3;26(1):110. doi: 10.1186/s13058-024-01869-8. ABSTRACT Breast cancer (BC) is a highly prevalent malignancy worldwide, with complex pathogenesis and treatment challenges. Research …
J Cardiothorac Surg. 2024 Jul 3;19(1):419. doi: 10.1186/s13019-024-02904-7. ABSTRACT BACKGROUND: Although mitral valve repair is the preferred surgical strategy in children with mitral valve disease, …
Orphanet J Rare Dis. 2024 Jul 3;19(1):248. doi: 10.1186/s13023-024-03267-x. ABSTRACT BACKGROUND: Primary carnitine deficiency (PCD) is a rare autosomal recessive fatty acid oxidation disorder caused …
Arch Public Health. 2024 Jul 3;82(1):99. doi: 10.1186/s13690-024-01315-3. ABSTRACT BACKGROUND: Previous studies have shown a growing need for pediatric palliative care, but there is a …
Clin Epigenetics. 2024 Jul 3;16(1):85. doi: 10.1186/s13148-024-01703-0. ABSTRACT BACKGROUND: Infants with frequent viral and bacterial respiratory infections exhibit compromised immunity to routine immunizations. They are …
BMC Genomics. 2024 Jul 3;25(1):668. doi: 10.1186/s12864-024-10578-7. ABSTRACT Hb H disease is the most severe form of α-thalassemia compatible with post-natal life. Compound heterozygous α0-thalassemia– …